Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.5901
+0.0400 (7.27%)
At close: Mar 31, 2026, 4:00 PM EDT
0.5800
-0.0101 (-1.71%)
After-hours: Mar 31, 2026, 7:14 PM EDT

Basel Medical Group Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22
1133---
Market Cap Growth
-85.13%----
Enterprise Value
8.533.34000
Last Close Price
0.591.78---
PE Ratio
--3.96---
PS Ratio
1.243.75---
PB Ratio
2.607.81---
P/TBV Ratio
2.046.15---
P/FCF Ratio
--9.23---
P/OCF Ratio
--10.50---
EV/Sales Ratio
0.953.74---
EV/EBITDA Ratio
--3.71---
EV/EBIT Ratio
--3.36---
EV/FCF Ratio
--9.21---
Debt / Equity Ratio
0.540.540.210.621.61
Debt / EBITDA Ratio
-4.74-0.441.622.873.72
Debt / FCF Ratio
-1.15-1.101.722.783.76
Net Debt / Equity Ratio
0.370.370.311.092.32
Net Debt / EBITDA Ratio
-1.90-0.180.882.383.15
Net Debt / FCF Ratio
-0.46-0.440.942.313.18
Asset Turnover
0.670.650.630.600.63
Inventory Turnover
30.4231.9070.6667.9288.93
Quick Ratio
1.231.232.032.272.17
Current Ratio
1.311.312.262.282.18
Return on Equity (ROE)
-190.36%-163.64%31.77%38.79%64.40%
Return on Assets (ROA)
-12.96%-69.32%11.53%12.15%12.78%
Return on Invested Capital (ROIC)
-30.49%-118.89%16.00%16.33%17.25%
Return on Capital Employed (ROCE)
-28.55%-142.69%23.48%21.09%22.30%
Earnings Yield
-75.35%-25.22%---
FCF Yield
-104.93%-10.84%---
Buyback Yield / Dilution
-15.60%-15.60%0.00%0.00%-
Total Shareholder Return
-15.60%-15.60%0.00%0.00%-
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q